Advanced search
Publication Cover
Leukemia & Lymphoma Volume 55, 2014 - Issue 7
Submit an article Journal homepage
257
Views
8
CrossRef citations to date
0
Altmetric
Letter

Autologous stem cell transplant can overcome poor prognosis in patients with multiple myeloma with extramedullary plasmacytoma

Jian LiDepartment of Hematology, Peking Union Medical College Hospital, Chinese Academy of Medical Sciences and Peking Union Medical College, Beijing, People's Republic of China
,
Kai-Ni ShenDepartment of Hematology, Peking Union Medical College Hospital, Chinese Academy of Medical Sciences and Peking Union Medical College, Beijing, People's Republic of China
,
Wen-Rong HuangDepartment of Hematology, Chinese PLA General Hospital, Beijing, People's Republic of China
,
Li-Hong LiDepartment of Hematology, Beijing Chao-Yang Hospital, Beijing, People's Republic of China
,
Huan ChenDepartment of Hematology, Peking University People's Hospital, Beijing, People's Republic of China
,
Wen-Ming ChenDepartment of Hematology, Beijing Chao-Yang Hospital, Beijing, People's Republic of China
,
Kai-Yan LiuDepartment of Hematology, Peking University People's Hospital, Beijing, People's Republic of China
,
Li YuDepartment of Hematology, Chinese PLA General Hospital, Beijing, People's Republic of China
&
Dao-Bin ZhouDepartment of Hematology, Peking Union Medical College Hospital, Chinese Academy of Medical Sciences and Peking Union Medical College, Beijing, People's Republic of ChinaCorrespondence[email protected]
 show all
Pages 1687-1690 | Received 13 May 2013, Accepted 03 Oct 2013, Published online: 04 Feb 2014

References

  • Varettoni M, Corso A, Pica G, et al. Incidence, presenting features and outcome of extramedullary disease in multiple myeloma: a longitudinal study on 1003 consecutive patients. Ann Oncol 2010; 21:325–330.
  • Wu P, Davies FE, Boyd K, et al. The impact of extramedullary disease at presentation on the outcome of myeloma. Leuk Lymphoma 2009;50:230–235.
  • Blade J, Kyle RA, Greipp PR. Presenting features and prognosis in 72 patients with multiple myeloma who were younger than 40 years. Br J Haematol 1996;93:345–351.
  • Blade J, Lust JA, Kyle RA. Immunoglobulin-D multiple-myeloma: presenting features, response to therapy, and survival in a series of 53 cases. J Clin Oncol 1994;12:2398–2404.
  • Usmani SZ, Heuck C, Mitchell A, et al. Extramedullary disease portends poor prognosis in multiple myeloma and is over-represented in high-risk disease even in the era of novel agents. Haematologica 2012;97:1761–1767.
  • Rosinol L, Cibeira T, Blade J, et al. Extramedullary multiple myeloma escapes the effect of thalidomide. Haematologica 2004;89:832–836.
  • Avigdor A, Raanani P, Levi I, et al. Extramedullary progression despite a good response in the bone marrow in patients treated with thalidomide for multiple myeloma. Leuk Lymphoma 2001;42:683–687.
  • Raanani P, Shpilberg O, Ben-Bassat I. Extramedullary disease and targeted therapies for hematological malignancies—is the association real?. Ann Oncol 2007;18:7–12.
  • Rosinol L, Cibeira MT, Martinez J, et al. Thalidomide/dexamethasone (TD) vs. bortezomib (Velcade)â/thalidomide/dexamethasone (VTD) vs. VBMCP/VBAD/Velcadeâ as induction regimens prior autologous stem cell transplantation (ASCT) in multiple myeloma (MM): results of a phase III PETHEMA/GEM trial. Blood 2009;114(Suppl. 1): Abstract 130.
  • Minnema MC, van de Donk NWCJ, Zweegman S, et al. Extramedullary relapses after allogeneic non-myeloablative stem cell transplantation in multiple myeloma patients do not negatively affect treatment outcome. Bone Marrow Transplant 2008;41:779–784.
  • Ali R, Ozkalemkas F, Ozkan A, et al. Bortezomib and extramedullary disease in multiple myeloma: the shine and dark side of the moon. Leuk Res 2007;31:1153–1155.
  • Alegre A, Granda A, Martinez-Chamorro C, et al. Different patterns of relapse after autologous peripheral blood stem cell transplantation in multiple myeloma: clinical results of 280 cases from the Spanish Registry. Haematologica 2002;87:609–614.
  • Perez-Simon JA, Sureda A, Fernandez-Aviles F, et al. Reduced-intensity conditioning allogeneic transplantation is associated with a high incidence of extramedullary relapses in multiple myeloma patients. Leukemia 2006;20:542–545.
  • Cerny J, Fadare O, Hutchinson L, et al. Clinicopathological features of extramedullary recurrence/relapse of multiple myeloma. Eur J Haematol 2008;81:65–69.
  • Blade J, de Larrea CF, Rosinol L, et al. Soft-tissue plasmacytomas in multiple myeloma: incidence, mechanisms of extramedullary spread, and treatment approach. J Clin Oncol 2011;29:3805–3812.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Order Reprints Request Corporate Permissions

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

Request Academic Permissions

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.

Related research

People also read lists articles that other readers of this article have read.

Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.

Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.